胸腔镜下亚肺叶切除治疗ⅠA期非小细胞肺癌的临床研究  

Clinical Study of Thoracoscopic Sublung Lobectomy for Stage IA Non small Cell Lung Cancer

作　　者：冯俊成[1] FENG Juncheng(Department of Cardiothoracic Surgery,Yixing People's Hospital,Yixing,Jiangsu Province,214200 China)

机构地区：[1]宜兴市人民医院心胸外科,江苏宜兴214200

出　　处：《中外医疗》2024年第12期65-68,共4页China & Foreign Medical Treatment

摘　　要：目的探究ⅠA期非小细胞肺癌患者应用胸腔镜下亚肺叶切除术治疗的效果。方法方便选取2022年7月—2023年12月宜兴市人民医院收治的92例ⅠA期非小细胞肺癌患者为研究对象。按Excel表格分组法均分为研究组和参照组,各46例。参照组给予胸腔镜下肺叶切除术治疗。研究组给予胸腔镜下亚肺叶切除术治疗。对比两组的手术指标、炎性因子水平及术后并发症发生情况。结果研究组手术指标均优于参照组,差异有统计学意义(P均<0.05);术前两组各炎性因子水平对比,差异无统计学意义(P均>0.05);术后,研究组炎性因子水平均低于参照组,差异有统计学意义(P均<0.05);研究组术后并发症发生率(4.35%)低于参照组(17.39%),差异有统计学意义(χ^(2)=4.039,P<0.05)。结论对比胸腔镜下肺叶切除术,胸腔镜下亚肺叶切除术治疗ⅠA期非小细胞肺癌患者的应用价值更高。患者手术指标及炎性因子水平改善,术后并发症减少,具有临床借鉴价值。Objective To investigate the effect of application of thoracoscopic sublung lobectomy in the treatment of stage IA non-small cell lung cancer patients.Methods A total of 92 patients admitted to Yixing People's Hospital from July 2022 to December 2023 conveniently were selected as study objects,and they were divided into study group and reference group by Excel table grouping method,with 46 cases each.The reference group was treated with thoracoscopic lobectomy.The study group was given thoracoscopic sublung lobectomy.The surgical indexes,inflammatory factor levels and the occurrence of postoperative complications were compared between the two groups.Results The surgical indexes of the study group were better than those of the reference group,and the differences were statistically significant(all P<0.05).Preoperative inflammatory factor levels were compared between the two groups,and the differences were not statistically significant(all P>0.05).Postoperatively,the levels of inflammatory factors in the study group were lower than those in the reference group,and the differences were statistically significant(all P<0.05).Postoperative complication rate in the study group(4.35%)were lower than in the reference group(17.39%),and the difference was statistically significant(χ^(2)=4.039,P<0.05).Conclusion Compared with thoracoscopic lobectomy,thoracoscopic sublung lobectomy has a higher application value in treating patients with stage IA non-small cell lung cancer.The patients'surgical indexes and inflammatory factor levels improved,and postoperative complications were reduced,which has clinical reference value.

关 键 词：胸腔镜下亚肺叶切除术 胸腔镜下肺叶切除术 ⅠA期非小细胞肺癌 手术指标 炎性因子水平 术后并发症 

分 类 号：R734[医药卫生—肿瘤]